18F-FDG PET/CT Versus 18F-FAPI PET/CT in Eosinophilic Liver Infiltration
Authors:
- 23 January 2025
- journal article
- interesting image
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 50 (8) , e483-e485
Abstract
A 48-year-old man presented with upper abdominal discomfort for 10 days. Abdominal contrast-enhanced CT showed multiple abnormal enhanced masses in liver, suggesting a probability of malignancies. The patient was then enrolled in a clinical trial of comparison of 18F-FDG and 18F-FAPI PET/CT in hepatic lesions. Compared with 18F-FDG PET/CT, 18F-FAPI PET/CT showed higher tracer uptake, more lesions in liver. Meanwhile, peripheral blood eosinophils increased remarkably. The hepatic lesions were highly suspected as eosinophilic liver infiltration. Finally, pathologic analysis confirmed the diagnosis of eosinophilic liver infiltration.Keywords
This publication has 9 references indexed in Scilit:
- Role of [18F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [18F]FDG PET/CTEJNMMI Research, 2024
- Intense 18F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18F-FDG PET/CTClinical Nuclear Medicine, 2024
- Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinomaCancer Imaging, 2023
- Increased 18F-FAPI Uptake in Radiation-Induced Liver InjuryClinical Nuclear Medicine, 2023
- [18F]FAPI PET/CT in the evaluation of focal liver lesions with [18F]FDG non-avidityEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CTClinical Nuclear Medicine, 2022
- Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- 68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic PatientClinical Nuclear Medicine, 2020
- World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2019